Endometriosis Research Center Challenges GnRH Agonist Usage Guidelines
A recent consensus statement regarding the use of GnRH agonists in the management of Endometriosis has prompted a challenging response from the Endometriosis Research Center. The consensus statement, released in a recent Journal of Fertility & Sterility, advocates the use of GnRH agonists such as Lupron in women who have not been surgically diagnosed with the disease. The ERC called such usage "unethical," and raised concerns about the lack of inclusion of well-regarded Endometriosis specialists on the consensus panel.
